Track Ra Medical Systems, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ra Medical Systems, Inc. RMED · Stock Open Ra Medical Systems, Inc. in new tab

0.5940 USD
Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Ra Medical Systems, Inc. (RMED)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Ra Medical Systems, Inc. Logo Ra Medical Systems, Inc. Analysis (RMED)

United States Health Care Official Website Stock

Is Ra Medical Systems, Inc. a good investment? Ra Medical Systems, Inc. (RMED) is currently trading at 0.5940 USD.

Investor FAQ

Does Ra Medical Systems, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Ra Medical Systems, Inc.?

Ra Medical Systems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Exchange Ticker
ASE (United States) RMED
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion